Gold tier: mechanically validated evidence, with its primary source.
369 evidence items · page 6 / 15
7 %Among hospitalized HIV-positive adults in West Africa who died, the underlying cause of death was other diseases in 7% of cases.
Côte d'IvoireVIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797
5 per_person_yearMorbidity among people living with HIV/AIDS during the first year of antiretroviral therapy implementation was 5–10% per person-year.
Côte d'IvoireVIH/sidapublished 2009Medecine tropicale : revue du Corps de sante colonialeurope_pmcdocument of 5 observations
16.97 yearsDiscounted life expectancy was 16.97 years with viral load confirmation of immunologic failure.
Côte d'IvoireVIH/sidapublished 2016Clinical infectious diseases : an official publication of the Infectious Diseases Society europe_pmcdocument of 5 observations
112 patients112 out of 491 adult HIV patients had CD4+ T-cell count less than 200/mm³.
Côte d'IvoireVIH/sidaobserved 2006published 2012World journal of hepatologyeurope_pmcdocument of 13 observations
53 yearsThe median age of the 95 HIV-2 patients in the cohort was 53 years, with an interquartile range of 47–60 years.
Côte d'IvoireVIH/sidapublished 2025PloS oneeurope_pmcdocument of 12 observations
34 %Among HIV-infected adults interviewed, 34% were in a stable partnership with a partner whose HIV serostatus they were not aware of.
Côte d'IvoireVIH/sidapublished 2014AIDS (London, England)europe_pmcdocument of 5 observations
43 %43% of the patients were initially classified as HIV-1&2 dually reactive.
Côte d'IvoireVIH/sidaobserved 2012published 2014Journal of the International AIDS Societyeurope_pmcdocument of 8 observations
78 %Four hundred seventy-seven patients included 78% women.
Côte d'IvoireVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 6 observations
74 casesAmong the 128 cases of non-occupational HIV exposure, 74 were due to rape.
Côte d'IvoireVIH/sidaobserved 2000-2007published 2010Medecine et maladies infectieuseseurope_pmcdocument of 13 observations
57 %57% of the patients were initially classified as HIV-2.
Côte d'IvoireVIH/sidaobserved 2012published 2014Journal of the International AIDS Societyeurope_pmcdocument of 8 observations
464 /mm3Among the 2056 patients, median CD4 count was 464/mm3 at baseline.
Côte d'IvoireVIH/sidapublished 2017PloS oneeurope_pmcdocument of 8 observations
79 %In the per-protocol analysis, HIV RNA less than 50 copies/ml at 24 weeks was observed in 23 of 29 (79%) patients in the ZDV arm.
Côte d'IvoireVIH/sidapublished 2017AIDS (London, England)europe_pmcdocument of 7 observations
-118.4 per_weekThe volume of HIV viral load tests performed decreased by 118.4 tests per week in Côte d'Ivoire after the beginning of the pandemic.
Côte d'IvoireVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 4 observations
30.3 %Among 66 HBsAg-positive patients, 30.3% had HBeAg-negative hepatitis.
Côte d'Ivoirehépatite B · VIH/sidaobserved 2006published 2012World journal of hepatologyeurope_pmcdocument of 13 observations
0 seroconversionsNo HIV and HBV seroconversion was observed after a 3-month follow-up among rape victims receiving antiretroviral chemoprophylaxis in Abidjan.
Côte d'Ivoirehépatite B · VIH/sidapublished 2015Medecine et maladies infectieuseseurope_pmcdocument of 3 observations
17.9 %Cerebral toxoplasmosis accounted for 17.9% of AIDS-defining reasons for hospitalization.
Côte d'Ivoirecerebral toxoplasmosis · VIH/sidapublished 2013Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument of 16 observations
8.6 %8.6% of patients interrupted antiretroviral chemoprophylaxis treatment.
Côte d'IvoireVIH/sidaobserved 2000-2007published 2010Medecine et maladies infectieuseseurope_pmcdocument of 13 observations
86 cells/mm³CD4(+) T-cell nadirs were 86 cells/mm³, 99 cells/mm³, and 12 cells/mm³ for the three patients.
Côte d'IvoireVIH/sidapublished 2009Antiviral therapyeurope_pmcdocument of 11 observations
13 patients13 patients had been treated (21%).
Côte d'IvoireVIH/sidaobserved 1999–2006published 2010Le Mali medicaleurope_pmcdocument of 17 observations
87 %At month 6, 87% of HIV-1-infected adults on zidovudine + lamivudine + efavirenz had undetectable viral load.
Côte d'IvoireVIH/sidaobserved month 6published 2006Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/01.qai.0000219777.04927.50
75 %At month 24 after ART initiation, 75% of patients with detectable viral loads had resistant virus.
Côte d'IvoireVIH/sidapublished 2013Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 11 observations
186 per_mm3The median pre-antiretroviral treatment CD4 count was 186 per mm³.
Côte d'IvoireVIH/sidapublished 2013BMC infectious diseaseseurope_pmcdocument of 10 observationsDOI 10.1186/1471-2334-13-607
77.3 %Among 130 patients who reported a relevant clinical indicator, 92 (77.3%) experienced at least one missed opportunity for HIV testing.
Côte d'IvoireVIH/sidaobserved 2013–2014published 2017PloS oneeurope_pmcdocument of 5 observations
4.7 %HIV prevalence was 4.7% in the referent group of 442 patients.
Côte d'IvoireVIH/sidapublished 2012PloS oneeurope_pmcdocument of 7 observationsDOI 10.1371/journal.pone.0048108
17.25 yearsDiscounted life expectancy was 17.25 years for adaptive viral load monitoring.
Côte d'IvoireVIH/sidapublished 2016Clinical infectious diseases : an official publication of the Infectious Diseases Society europe_pmcdocument of 5 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.